NCT07535801Recruiting
Recording Stress Biomarkers in Autism Spectrum Disorders
Biophysiological Characterization of Stress in Autism Spectrum Disorders: Analysis of Peripheral Markers of the ANS and the HPA Axis
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to learn how stress affects children and young people with autism spectrum disorder (ASD). Many individuals with autism experience strong stress reactions that may lead to challenging behaviours such as agitation, withdrawal, aggression, or self-injury. These behaviours can be difficult to predict, especially in people who have limited communication abilities. Researchers want to better understand how the body reacts to stress in real-life situations. The study focuses on two main biological systems involved in the stress response: the autonomic nervous system, which produces fast reactions such as changes in heart rate and sweating, and the hypothalamic-pituitary-adrenal axis, which produces slower hormonal responses such as cortisol. The main questions the study aims to answer are: * Do physiological stress signals differ between individuals with ASD and those without ASD? * Are there differences in physiological stress responses between individuals with ASD and non-ASD participants? * Can physiological markers help identify stress earlier in people with autism? Researchers will compare children and young people with autism to a control group of participants without autism to see whether their stress responses differ. Participants will take part in monitoring during their normal daily activities. This allows researchers to observe stress responses in natural environments such as school, home, or specialized care institutions. Participants will: * Wear a wrist device during the day that measures heart rate, heart rate variability, skin conductance, skin temperature, and movement * Provide saliva samples in the morning and afternoon to measure stress hormones such as cortisol and alpha-amylase * Have additional saliva samples collected after behavioural crises or stressful events when possible * Be observed by a trained researcher who records behavioural events and the surrounding context Researchers will combine physiological data, behavioural observations, and contextual information such as physical activity, environmental conditions, and daily routines. This will help identify patterns of stress in everyday life. The results of this study may help researchers better understand the physiology of stress in autism and support the future development of wearable systems that could detect stress early and help prevent behavioural crises.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 13 Mar 2026
- Start date
- 23 Mar 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Universite Cote d'Azur
- Diseases
- Autism
- NCT number
- NCT07535801
What you commit to
- Study type: Observational
- Planned participants: 60
- From 23 Mar 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known cardiac or homonal disorders that may interfere with physiological monitoring
- No diagnosis of autism spectrum disorder or other neurodevelopmental disorder
- No history of major psychiatric or neurological disorders
- Known cardiac or hormonal disorders affecting physiological measurements
- Current diagnosis of neurodevelopmental or psychiatric disorder
Age
- Age between 3 and 22 years
Other
- Lack of consent from parents or legal guardians
- Control Group (Neurotypical Participants) Inclusion Criteria
- Written informed consent provided by a parent or legal guardian
- Assent from the participant when developmentally appropriate
- Lack of parental or guardian consent
Criteria the registry did not label
- Autism Spectrum Disorder (ASD) Group Inclusion Criteria
- Age between 3 and 22 years
- Clinical diagnosis of autism spectrum disorder according to established diagnostic criteria
- Presence of recurrent behavioral crises (minimum of three episodes per week)
- Enrollment in a participating institution or care structure
- Written informed consent provided by a parent or legal guardian
- Assent from the participant when developmentally appropriate
Age in the registry: 3 years to 22 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CoBTEk Coordinator of this site? Confirm its status | Nice | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.